Aclarion Plunges 29.18% Amid Reverse Stock Split

Aclarion's stock price plummeted by 29.18% in pre-market trading on March 26, 2025, marking a significant downturn for the healthcare technology company.

Aclarion recently announced a reverse stock split at a ratio of 1-for-27. This move, approved by the Board, involves amending the company's Certificate of Incorporation. Such actions are typically taken to boost the stock price by reducing the number of outstanding shares, which can make the stock more attractive to investors by increasing its per-share value.

Additionally, Aclarion has been featured in the Vickers Top Insider Picks report, which highlights companies with notable insider purchase activities over the past three months. This recognition suggests that there may be positive sentiment among insiders regarding the company's future prospects, despite the recent stock price decline.